Skip to main content
DOUBLE MEDICAL TECHNOLOGY INC. logo

DOUBLE MEDICAL TECHNOLOGY INC. — Investor Relations & Filings

Ticker · 002901 ISIN · CNE1000032W7 LEI · 836800DECKX5CGFNMD42 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 963 across all filing types
Latest filing 2021-05-14 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002901

About DOUBLE MEDICAL TECHNOLOGY INC.

https://www.double-medical.com

Double Medical Technology Inc. specializes in the development, manufacturing, and distribution of medical devices, with a primary focus on orthopedic solutions. The company's extensive product portfolio includes trauma fixation systems, spinal implants, joint prosthesis, and neurosurgical devices. Additionally, it provides specialized surgical instruments and advanced wound care products. Double Medical emphasizes research and innovation to deliver clinically effective solutions for complex musculoskeletal conditions. Its manufacturing processes adhere to international quality standards, ensuring the reliability of its implants and instruments used in hospitals and surgical centers worldwide. The company serves a global market, providing comprehensive support for orthopedic surgeons through its diverse range of reconstructive and regenerative medical technologies.

Recent filings

Filing Released Lang Actions
关于调整2021年限制性股票激励计划首次授予部分激励对象名单和授予数量的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding adjustments to the 2021 restricted stock incentive plan, specifically changes to the list of incentive recipients and the number of shares granted. It details board and shareholder meeting approvals, independent director opinions, and legal opinions related to the stock incentive plan. The content focuses on corporate governance and management decisions about stock incentives rather than financial results or detailed financial statements. It is not a full annual or interim report, earnings release, or audit report. It is also not a proxy solicitation or voting results announcement. The document is a formal announcement of management decisions related to stock incentives, which fits best under the category of Regulatory Filings (RNS) as it does not fit more specific categories like Remuneration Information or Share Issue/Capital Change, since it is about adjustments to an incentive plan rather than new share issuance or executive compensation details. The document length is short and it is an announcement rather than a full report, so it is not a report publication announcement (RPA).
2021-05-14 Chinese
关于向激励对象首次授予限制性股票的公告
Share Issue/Capital Change Classification · 95% confidence The document is a detailed announcement regarding the initial grant of restricted shares under a stock incentive plan by the company 大博医疗科技股份有限公司. It includes specifics about the grant date, number of shares, price, eligibility, performance conditions, approval procedures, and legal opinions. The content focuses on the company's equity incentive plan and the granting of restricted stock to employees and management. This type of document is a formal announcement about a capital change related to share issuance to employees as part of an incentive plan. It is not a financial report, earnings release, or management discussion, nor is it a proxy or voting result announcement. It fits best under the category of Share Issue/Capital Change (SHA), which covers announcements regarding new share issues or capital changes such as stock grants or restricted stock issuance.
2021-05-14 Chinese
大博医疗科技股份有限公司前次募集资金使用情况鉴证报告
Audit Report / Information Classification · 95% confidence The document is titled as a "鉴证报告" (Verification Report) on the "前次募集资金使用情况" (Previous Fundraising Usage Situation) for 大博医疗科技股份有限公司. It includes detailed financial data about the use of previously raised funds, bank account balances, investment projects, and cash management related to fundraising. The report is prepared by the company's board and verified by a registered accounting firm, referencing compliance with regulations from the China Securities Regulatory Commission. The document is about the usage of previously raised capital and includes an auditor's verification conclusion, but it is not a full annual report or interim financial report. It is a standalone audit-related report focusing on the use of fundraising proceeds, which fits the definition of an Audit Report / Information (AR). The document length (8081 characters) and content confirm it is a full report, not just an announcement or certification letter, so it is not RPA or RNS. Therefore, the best classification is AR with high confidence. FY 2020
2021-05-14 Chinese
关于召开2021年第三次临时股东大会的通知
AGM Information Classification · 100% confidence The document is a detailed notice about convening the 2021 third extraordinary general meeting of shareholders for a company, including information on meeting date, voting procedures (both in-person and online), agenda items to be voted on, registration details, and attachments such as proxy forms and voting instructions. It does not contain financial statements, earnings data, or management discussion and analysis. It is not an announcement of voting results but a notice to shareholders about the meeting and how to participate and vote. This fits the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings.
2021-05-14 Chinese
关于收购北京安德思考普商贸有限公司51%股权的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement about the acquisition of 51% equity in Beijing Andesi Kaopu Trading Co., Ltd. by Dabao Medical Technology Co., Ltd. It includes transaction overview, company details, financial data, transaction terms, and impact analysis. The document is a formal announcement of a capital investment transaction, including purchase price, payment terms, and risk disclosures. It is not a full financial report, audit report, or earnings release. It is not a regulatory filing or report publication announcement since it contains substantive transaction details and financial data. The content fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes through acquisition.
2021-05-14 Chinese
第二届董事会第十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of the company, detailing decisions on stock incentive plans, acquisitions, use of raised funds, and scheduling of a shareholders meeting. It includes voting results and references to related announcements published elsewhere. The content focuses on board decisions and management actions rather than financial statements or detailed financial results. It is not a full annual or interim report, nor an earnings release or audit report. The document is a board meeting resolution announcement, which fits the category of Board/Management Information (MANG). The document length is 2386 characters, which is relatively short and consistent with a meeting resolution announcement rather than a full report.
2021-05-14 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.